Eupraxia Pharmaceuticals Inc.

NASDAQ:EPRX

Biotechnology

Healthcare
$6.21 +1.11%

+$0.07 today

Market cap
$417.57M
Beta
1.48
P/E (TTM)
-8.5
EPS (TTM)
-$0.74
52W Low $4.19High $9.32

Volume 1.21M

Average 0.22M

Balance Sheet

Inspect the capital base behind the business.

Assets

$86.15M

FY 2025 · Annual

+146.5% YoY

Liabilities

$5.70M

FY 2025 · Annual

+83.8% YoY

Equity

$80.45M

FY 2025 · Annual

+152.7% YoY

Balance Sheet

Mixed currencies
Metric
FY2021
Dec 2021 · CAD
FY2022
Dec 2022 · CAD
FY2023
Dec 2023 · USD
FY2024
Dec 2024 · USD
FY2025
Dec 2025 · USD
Cash & Equivalents20.89M24.73M14.56M33.1M80.56M
Short-term Investments9.01M0000
Net Receivables00143.52K228.87K674.23K
Inventory00000
Other Current Assets429.72K121.47K000
Total Current Assets30.6M25.17M14.91M34.44M85.1M
Property, Plant & Equipment (Net)589.07K718.61K343.52K424.92K987.13K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets31.37K3.37K5.2K80.76K64.33K
Total Non-current Assets620.44K721.98K348.72K505.68K1.05M
Total Assets31.22M25.89M15.26M34.94M86.15M
Account Payables00000
Short-term Debt94.92K107.53K7.83M078.31K
Tax Payables0027.42K00
Deferred Revenue00000
Other Current Liabilities5.01K21.66K646.48K1.49M(78.31K)
Total Current Liabilities2.27M4.14M14.59M3.1M5.63M
Long-term Debt9.7M11.92M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities9.84M11.99M0075.91K
Total Liabilities12.1M16.13M14.59M3.1M5.7M
Common Stock77.65M96.13M69.96M116.36M195.41M
Retained Earnings(74.26M)(104.63M)(79.43M)(131M)(169.58M)
Accumulated OCI16.56M(3.77M)(2.04M)(4.16M)(2.04M)
Other Stockholders Equity0(931)000
Minority Interest(833.84K)(783.49K)(996.78K)(1.57M)(1.6M)
Total Equity19.12M9.76M671.86K31.84M80.45M
Total Debt9.99M12.17M7.87M71.86K154.36K
Net Debt(10.9M)(12.56M)(6.69M)(33.03M)(80.41M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$58.7M
Short-term Investments$80.6M
Receivables$665.4K
Other Current$2.6M
Total Current Assets$142.6M
PP&E (Net)$3.2M
Other Non-current$62.0K
Total Non-current Assets$3.2M
Total Assets$145.8M

Analysis

Selected assets total $145.8M for Latest. The largest visible component is Short-term Investments at $80.6M, about 55.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-8S-8 filingNov 12, 2026
6-K6-K filingNov 10, 2026
6-K6-K filingNov 10, 2026
6-K6-K filingNov 10, 2026
6-K6-K filingNov 10, 2026

How much cash does EPRX have?

Eupraxia Pharmaceuticals Inc. (EPRX) reported $80.56M in cash and equivalents in fiscal 2025.

How much debt does EPRX carry?

Eupraxia Pharmaceuticals Inc. (EPRX) reported $154,362.00 of total debt, with net debt of -$80.41M.